Monica Gio-Batta1, Karin Spetz2, Malin Barman3,4, Lennart Bråbäck5, Elisabeth Norin6, Bengt Björkstén7, Agnes E Wold1, Anna Sandin2. 1. Institute of Biomedicine, Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 2. Department of Clinical Science, Pediatrics, Sunderby Research Unit, Umeå University, Umeå, Sweden. 3. Department of Biology and Biological Engineering, Food and Nutrition Science, Chalmers University of Technology, Gothenburg, Sweden. 4. Institute of Environmental Medicine, Unit of Metals and Health, Karolinska Institutet, Stockholm, Sweden. 5. Section of Sustainable Health, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden. 6. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. 7. Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Abstract
BACKGROUND: Short-chain fatty acids (SCFAs) are abundant bacterial metabolites in the gut, with immunomodulatory properties. Hence, they may influence allergy development. Previous studies have linked fecal SCFA pattern during infancy with allergy. However, the association of SCFAs to allergic outcomes in adolescence is not well established. Here, we examined how the fecal SCFA pattern at 1 year of age related to allergy at 13 years of age. METHODS: Levels of 8 SCFAs in fecal samples collected at 1 year of age from 110 children were quantified using gas chromatography. The same individuals were evaluated at 13 years of age for allergic symptoms, allergy diagnosis and allergy medication by questionnaire, and for sensitization using skin prick test against egg, milk, fish, wheat and soy, cat, dog, horse, birch, and timothy grass. RESULTS: The concentration of fecal valeric acid at 1 year of age was inversely associated with eczema at 13 years of age (OR 0.6, 95% CI: 0.4-1.0, p = 0.049) and showed a trend for inverse association with food allergy at 13 years of age (OR 0.6, 95% CI: 0.4-1.0, p = 0.057). In a sub-group analysis of children with eczema at 1 year of age, a higher concentration of fecal valeric acid was linked with reduced risk of their eczema remaining at 13 years of age (OR 0.2, 95% CI: 0.0-1.5), although this latter analysis did not reach statistical significance (p = 0.12). CONCLUSIONS: Our findings lend further support to the notion of early childhood as a critical period when allergy may be programmed via the gut microbiota. Higher levels of fecal valeric acid may be characteristic of a protective gut microbiota and/or actively contribute to protection from eczema and food allergy.
BACKGROUND: Short-chain fatty acids (SCFAs) are abundant bacterial metabolites in the gut, with immunomodulatory properties. Hence, they may influence allergy development. Previous studies have linked fecal SCFA pattern during infancy with allergy. However, the association of SCFAs to allergic outcomes in adolescence is not well established. Here, we examined how the fecal SCFA pattern at 1 year of age related to allergy at 13 years of age. METHODS: Levels of 8 SCFAs in fecal samples collected at 1 year of age from 110 children were quantified using gas chromatography. The same individuals were evaluated at 13 years of age for allergic symptoms, allergy diagnosis and allergy medication by questionnaire, and for sensitization using skin prick test against egg, milk, fish, wheat and soy, cat, dog, horse, birch, and timothy grass. RESULTS: The concentration of fecal valeric acid at 1 year of age was inversely associated with eczema at 13 years of age (OR 0.6, 95% CI: 0.4-1.0, p = 0.049) and showed a trend for inverse association with food allergy at 13 years of age (OR 0.6, 95% CI: 0.4-1.0, p = 0.057). In a sub-group analysis of children with eczema at 1 year of age, a higher concentration of fecal valeric acid was linked with reduced risk of their eczema remaining at 13 years of age (OR 0.2, 95% CI: 0.0-1.5), although this latter analysis did not reach statistical significance (p = 0.12). CONCLUSIONS: Our findings lend further support to the notion of early childhood as a critical period when allergy may be programmed via the gut microbiota. Higher levels of fecal valeric acid may be characteristic of a protective gut microbiota and/or actively contribute to protection from eczema and food allergy.
Authors: I Adlerberth; F Jalil; B Carlsson; L Mellander; L A Hanson; P Larsson; K Khalil; A E Wold Journal: Epidemiol Infect Date: 1998-12 Impact factor: 2.451
Authors: Khanh Vu; Wendy Lou; Hein M Tun; Theodore B Konya; Nadia Morales-Lizcano; Radha S Chari; Catherine J Field; David S Guttman; Rupasri Mandal; David S Wishart; Meghan B Azad; Allan B Becker; Piush J Mandhane; Theo J Moraes; Diana L Lefebvre; Malcolm R Sears; Stuart E Turvey; Padmaja Subbarao; James A Scott; Anita L Kozyrskyj Journal: Gastroenterology Date: 2020-09-16 Impact factor: 22.682
Authors: Hsin Yue Cheng; James Chun Yip Chan; Gaik Chin Yap; Chiung-Hui Huang; Dorinda Yan Qin Kioh; Elizabeth Huiwen Tham; Evelyn Xiu Ling Loo; Lynette P C Shek; Neerja Karnani; Anne Goh; Hugo P S Van Bever; Oon Hoe Teoh; Yiong Huak Chan; Christophe Lay; Jan Knol; Fabian Yap; Kok Hian Tan; Yap-Seng Chong; Keith M Godfrey; Eric Chun Yong Chan; Bee Wah Lee; Le Duc Huy Ta Journal: Front Allergy Date: 2022-04-06